Literature DB >> 3061807

Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells.

R M Kypta1, A Hemming, S A Courtneidge.   

Abstract

fyn is a member of the growing family of protein tyrosine kinase genes whose sequences are highly related to that of c-src. We have generated antibodies to peptides corresponding to two different amino-terminal sequences encoded by this gene. Antisera to both peptides recognized a 59 kd protein from human and mouse fibroblasts. p59fyn was phosphorylated in vivo on serine and tyrosine residues and was also myristylated. Furthermore, immune precipitates of p59fyn had tyrosine kinase activity in vitro, as measured by autophosphorylation and by phosphorylation of substrates such as enolase. This kinase activity was shown to be negatively regulated by tyrosine phosphorylation. We have also established that, like pp60c-src and p62c-yes, p59fyn was complexed with middle T antigen, the transforming protein of polyoma virus. However, the tyrosine kinase activity of p59fyn was not elevated in middle T transformed cells. Possible explanations for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061807      PMCID: PMC454962          DOI: 10.1002/j.1460-2075.1988.tb03269.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Structure, expression, and chromosomal location of the human c-fgr gene.

Authors:  M Nishizawa; K Semba; M C Yoshida; T Yamamoto; M Sasaki; K Toyoshima
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

2.  Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation.

Authors:  M S Collett; E Erikson; R L Erikson
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Detection and quantification of phosphotyrosine in proteins.

Authors:  J A Cooper; B M Sefton; T Hunter
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

4.  Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation.

Authors:  D Bryant; J T Parsons
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

5.  Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation.

Authors:  F R Cross; H Hanafusa
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

6.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses.

Authors:  L A Lipsich; A J Lewis; J S Brugge
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

7.  Cyclic AMP treatment of Rous sarcoma virus-transformed Chinese hamster ovary cells increases phosphorylation of pp60src and increases pp60src kinase activity.

Authors:  C W Roth; N D Richert; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

8.  Small deletion in src of Rous sarcoma virus modifying transformation phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity.

Authors:  N Kitamura; M Yoshida
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

9.  Polyoma virus transforming protein associates with the product of the c-src cellular gene.

Authors:  S A Courtneidge; A E Smith
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

10.  The complex of polyoma virus middle-T antigen and pp60c-src.

Authors:  S A Courtneidge; A E Smith
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  54 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns.

Authors:  M J Fry; G Panayotou; R Dhand; F Ruiz-Larrea; I Gout; O Nguyen; S A Courtneidge; M D Waterfield
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

3.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.

Authors:  A D Beyers; L L Spruyt; A F Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase.

Authors:  E T Ulug; A J Cartwright; S A Courtneidge
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Authors:  A L Burkhardt; J B Bolen; E Kieff; R Longnecker
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  Transformation by hamster polyomavirus: identification and functional analysis of the early genes.

Authors:  L Goutebroze; J Feunteun
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator.

Authors:  P Lemaire; C Vesque; J Schmitt; H Stunnenberg; R Frank; P Charnay
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

8.  Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.

Authors:  S H Cheng; P C Espino; J Marshall; R Harvey; A E Smith
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

9.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.

Authors:  S M Dilworth; V P Horner
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.